Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
1(33.3%)
Phase 2
1(33.3%)
Phase 4
1(33.3%)
3Total
N/A(1)
Phase 2(1)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06352788Not ApplicableRecruiting

From Opinion to Evidence: Multi-site Evaluation of Custom Dynamic Orthosis Best Practices

Role: collaborator

NCT06273462Phase 2Recruiting

Palmitoylethanolamide for Chronic Inflammatory Pain Conditions

Role: lead

NCT05912023Active Not Recruiting

Perioperative Vaping Complications

Role: lead

NCT05587231Phase 4Unknown

Comparison of the Postoperative Use of Dextenza vs a Standard Regimen After PRK

Role: lead

All 4 trials loaded